Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed at $17.73 down -0.62% from its previous closing price of $17.84. In other words, the price has decreased by -$0.62 from its previous closing price. On the day, 16.16 million shares were traded. TEVA stock price reached its highest trading level at $18.32 during the session, while it also had its lowest trading level at $17.73.
Ratios:
For a deeper understanding of Teva- Pharmaceutical Industries Ltd. ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.34. For the most recent quarter (mrq), Quick Ratio is recorded 0.61 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 3.18 whereas as Long-Term Debt/Eq ratio is at 2.75.
On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.
Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 20 ’24 when MIGNONE ROBERTO sold 286,000 shares for $22.01 per share. The transaction valued at 6,294,031 led to the insider holds 695,000 shares of the business.
Bridger Management, LLC (1) bought 286,000 shares of TEVA for $6,094,660 on Dec 20 ’24. On Nov 20 ’24, another insider, Fox Christine, who serves as the EVP, Head of U.S. Commercial of the company, sold 19,388 shares for $16.87 each. As a result, the insider received 327,085 and left with 44,104 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 20157769728 and an Enterprise Value of 40669573120. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.20 while its Price-to-Book (P/B) ratio in mrq is 3.32. Its current Enterprise Value per Revenue stands at 2.425 whereas that against EBITDA is 8.498.
Stock Price History:
The Beta on a monthly basis for TEVA is 0.71, which has changed by 0.43214858 over the last 52 weeks, in comparison to a change of 0.22208416 over the same period for the S&P500. Over the past 52 weeks, TEVA has reached a high of $22.80, while it has fallen to a 52-week low of $11.62. The 50-Day Moving Average of the stock is -9.51%, while the 200-Day Moving Average is calculated to be 0.69%.
Shares Statistics:
For the past three months, TEVA has traded an average of 10.80M shares per day and 16627650 over the past ten days. A total of 1.13B shares are outstanding, with a floating share count of 1.13B. Insiders hold about 0.00% of the company’s shares, while institutions hold 57.18% stake in the company. Shares short for TEVA as of 1736899200 were 15797023 with a Short Ratio of 1.46, compared to 1734048000 on 23220122. Therefore, it implies a Short% of Shares Outstanding of 15797023 and a Short% of Float of 1.39999995.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 2.95.